Summary
Samenvatting module 3 THIM
- Course
- Institution
Deze samenvatting bevat alle onderdelen die aan bod komen in module 3. Deze samenvatting kan worden gebruikt om voor de theorietoets te leren.
[Show more]
8 reviews
By: michelheus • 2 year ago
By: anouckvanooijen • 2 year ago
By: freestyle2bars • 2 year ago
By: JBSD • 1 year ago
By: ThomasCB • 2 year ago
By: johanneslutgens • 2 year ago
By: demiverploegh • 2 year ago
Seller
Follow
margotvanvelzen
Reviews received
Content preview
SAMENVATTING MODULE 3,Inhoudsopgave
WEEK 1 Motorisch leren / anatomie hersenen ........................................................................................................... 5
Indeling van de hersenen ............................................................................................................................................................ 5
Anatomische indeling van het zenuwstelsel......................................................................................................................... 7
Prikkel ........................................................................................................................................................................................... 11
Zenuwgeleiding ......................................................................................................................................................................... 11
Sensoren ....................................................................................................................................................................................... 12
Hiërarchisch model van het zenuwstelsel ..................................................................................................................... 14
Leren en geheugen ................................................................................................................................................................... 15
De bouwstenen: habituatie en sensitisatie ................................................................................................................... 19
Shared decision making ......................................................................................................................................................... 21
Patiënt specifieke goalsetting methode .......................................................................................................................... 21
Motorisch leren ......................................................................................................................................................................... 24
WEEK 2 Motorisch leren ................................................................................................................................................ 26
Plasticiteit van het brein ....................................................................................................................................................... 26
Motorisch leren Framework ................................................................................................................................................ 27
WEEK 3 Onderzoek CVA patiënt ................................................................................................................................ 30
Herstelvermogen – centrale zenuwstelsel .................................................................................................................... 30
Herstel van perifeer zenuwstelsel .................................................................................................................................... 31
Fase van herstel sensibel ...................................................................................................................................................... 34
Fase van herstel motorisch .................................................................................................................................................. 35
Herstel mechanismen ............................................................................................................................................................. 37
Symptomen na een CVA ......................................................................................................................................................... 38
Symptomen CVA ....................................................................................................................................................................... 38
Onderzoek CVA: ........................................................................................................................................................................ 41
Wat-hoe-waarom, onderzoeksplan .................................................................................................................................. 42
Revalidatie opbouw in fasen volgens KNGF-richtlijn ............................................................................................... 42
Meetinstrumenten die kunnen worden toegepast en het doel daarvan .......................................................... 45
Behandeldomeinen bij CVA patiënten: ........................................................................................................................... 48
WEEK 4 ............................................................................................................................................................................... 49
Hersenregio’s en functies en de mogelijke symptomen bij een CVA in hersenregio’s .............................. 49
Spasticiteit ................................................................................................................................................................................... 52
Houdingsregulatie mechanismen...................................................................................................................................... 53
Feedback en feedforward: correctie en anticipatie................................................................................................... 54
De spierspoel: lengteregulatie ............................................................................................................................................ 54
De peessensor: spanningsregulatie .................................................................................................................................. 55
Overzicht houdingsregulatie ............................................................................................................................................... 56
Verschillende revalidatiefasen ........................................................................................................................................... 59
WEEK 5 ............................................................................................................................................................................... 61
Neglect ........................................................................................................................................................................................... 61
Vormen van neglect ................................................................................................................................................................. 61
Ruimtedomein ........................................................................................................................................................................... 63
Arousal, aandacht en aandachtsstoornissen ................................................................................................................ 64
Behandelmethoden neglect ................................................................................................................................................. 67
Trainen bij neglect ................................................................................................................................................................... 67
Hemiplegische schouder ....................................................................................................................................................... 68
WEEK 6 Dwarsleasie ....................................................................................................................................................... 70
Cirkel van Willis ........................................................................................................................................................................ 73
American Spinal Injury Association Impairment Scale (ASIA SCHAAL) ......................................................... 74
2
, Soorten ruggenmerg aandoeningen ................................................................................................................................. 74
Spinaal spasme .......................................................................................................................................................................... 75
WEEK 7 MS, GB, ALS en Polyneuropathie............................................................................................................... 78
Neuroanatomie van het zenuwstelsel en zenuwweefsel ........................................................................................ 78
Functie van perifere zeunuwen en het proces van veranderde geleiding van zenuwweefsel bij MS . 79
Mechanismen die leiden tot pathologische vermoeidheid bij een MS patiënt .............................................. 82
Meetinstrumenten om vermoeidheid van een ms patiënt te inventariseren ................................................ 82
Pathologie en symptomatologie van ALS, poly neuropathie, Guillain Barre en MS .................................... 84
Motorisch leren ......................................................................................................................................................................... 90
Begeleiding fysiotherapeut bij MS .................................................................................................................................... 90
De AMBC-gedragscirkel, cognitieve gedragstherapie .............................................................................................. 94
MS .................................................................................................................................................................................................... 96
Exacerbaties (longaanval) .................................................................................................................................................... 97
Vormen MS .................................................................................................................................................................................. 98
WEEK 8 Gezond ouder worden (Frailty) ................................................................................................................ 102
Meetinstrumenten ................................................................................................................................................................. 104
Kwetsbaarheid frailty ........................................................................................................................................................... 105
Intake ........................................................................................................................................................................................... 107
WEEK 9 Dementie ......................................................................................................................................................... 111
Cognitie ....................................................................................................................................................................................... 111
Global deteriation scale (GDS) .......................................................................................................................................... 113
Symptomen: .............................................................................................................................................................................. 115
Alzheimer ................................................................................................................................................................................... 116
Vasculaire dementie .............................................................................................................................................................. 117
Lewy body dementie ............................................................................................................................................................. 117
Fronto-temporale dementie .............................................................................................................................................. 118
Verschillende fasen van dementie .................................................................................................................................. 119
Verwardheid bij ouderen .................................................................................................................................................... 120
Achteruitgang hersenen ...................................................................................................................................................... 120
WEEK 10 Morbus Parkinson...................................................................................................................................... 124
Parkinson ................................................................................................................................................................................... 124
Parkinsonisme ......................................................................................................................................................................... 129
KNGF richtlijn Parkinson .................................................................................................................................................... 130
Ziekte stadia .............................................................................................................................................................................. 131
Fysiotherapie bij Parkinson ............................................................................................................................................... 131
WEEK 11 Comorbiditeit Hartrevalidatie ................................................................................................................ 140
De student beschrijft van veel voorkomende hart- en vaataandoeningen wat de aandoening inhoudt, hoe het
gediagnosticeerd wordt en met welke middelen het behandeld wordt. ....................................................................... 142
De verschillen tussen coronair lijden en hartfalen............................................................................................................. 145
Prikkelgeleidingssysteem ................................................................................................................................................... 150
Bloeddrukregulatie ................................................................................................................................................................ 151
Het lymfesysteem ................................................................................................................................................................... 153
KNGF-richtlijn .......................................................................................................................................................................... 156
Coronair lijden ......................................................................................................................................................................... 159
Hartfalen ..................................................................................................................................................................................... 160
WEEK 12 Comorbiditeit longrevalidatie ................................................................................................................. 198
De verschillen tussen copd en astma ............................................................................................................................. 200
Respiratoire systeem ............................................................................................................................................................ 202
Fysiotherapeutisch doel ...................................................................................................................................................... 203
3
, WEEK 13 Comorbiditeit longrevalidatie ................................................................................................................. 223
Exacerbaties ............................................................................................................................................................................... 223
Beïnvloeden factoren die een exacerbatie kunnen veroorzaken dan wel kunnen voorkomen. ......... 223
Fysiologie.......................................................................................................................................................................................... 226
FMH .................................................................................................................................................................................................... 230
WEEK 14 .......................................................................................................................................................................... 240
Pathologie ......................................................................................................................................................................................... 244
Cancer related Fatique ......................................................................................................................................................... 255
FMH .............................................................................................................................................................................................. 256
Meetinstrumenten ................................................................................................................................................................. 259
Inclusiecriteria ......................................................................................................................................................................... 260
Verhogen van het maximale aerobe uhv ...................................................................................................................... 263
Vergroten van de kracht van lokale spiergroepen en het spieruithoudingsvermogen .......................... 263
DTF ................................................................................................................................................................................................ 263
Oncologie en rode vlaggen ................................................................................................................................................. 263
Monoklonale antililichamen .............................................................................................................................................. 265
Lymfoedeem bij borstkanker ............................................................................................................................................ 266
WEEK 15 Osteoporose.................................................................................................................................................. 269
Diagnostiek ................................................................................................................................................................................ 277
Week 16 Looptraining ................................................................................................................................................... 284
Perry ............................................................................................................................................................................................. 285
Loopafwijkingen ..................................................................................................................................................................... 288
4
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller margotvanvelzen. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $8.68. You're not tied to anything after your purchase.
Can Stuvia be trusted?
4.6 stars on Google & Trustpilot (+1000 reviews)
77254 documents were sold in the last 30 days
Founded in 2010, the go-to place to buy study notes for 14 years now